Dynamics of viremia in primary HIV-1 infection in Africans: Insights from analyses of host and viral correlates

Virology

Volumn 449, Issue , 2014, Pages 254-262

  Prentice, Heather A ^a   Price, Matthew A ^b,c   Porter, Travis R ^a   Cormier, Emmanuel ^d,n   Mugavero, Michael J ^e   Kamali, Anatoli ^f   Karita, Etienne ^g   Lakhi, Shabir ^h   Sanders, Eduard J ^i,j   Anzala, Omu ^k   Amornkul, Pauli N ^b   Allen, Susan ^h,l   Hunter, Eric ^m   Kaslow, Richard A ^a,o   Gilmour, Jill ^d   Tang, Jianming ^a,e  

^a Memphis   (United States)

^b INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e University of Alabama at Birmingham   (United States)

^f MRC/UVRI Uganda Virus Research Unit on AIDS   (Uganda)

^g Projet San Francisco   (Rwanda)

^h Zambia Emory HIV Research Project   (Zambia)

ⁱ KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k Kenya AIDS Vaccine Initiative (KAVI)   (Kenya)

^l EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m EMORY UNIVERSITY   (United States)

ⁿ CRUCELL HOLLAND BV   (Netherlands)

^o DEPARTMENT OF VETERANS AFFAIRS   (United States)

more..

Author keywords

Africa; HIV 1; HLA; Statistical models; Subtype; Viral load

Indexed keywords

HLA B ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KENYA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RWANDA; SEROCONVERSION; UGANDA; VIREMIA; VIRUS CELL INTERACTION; VIRUS LOAD; ZAMBIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AFRICA; HIV-1; HLA; STATISTICAL MODELS; SUBTYPE; VIRAL LOAD;

ADULT; AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; VIRAL LOAD; VIREMIA;

EID: 84890158413     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.11.024     Document Type: Article

References (54)

1. Amornkul, Karita, Kamali, Rida, Sanders, Lakhi, Price, Kilembe, Cormier, Anzala, Latka, Bekker, Allen, Gilmour and Fast, Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa, AIDS PMCID: PMC3815107, in press.
2. Apps R., Qi Y., Carlson J.M., Chen H., Gao X., Thomas R., Yuki Y., Del Prete G.Q., Goulder P., Brumme Z.L., Brumme C.J., John M., Mallal S., Nelson G., Bosch R., Heckerman D., Stein J.L., Soderberg K.A., Moody M.A., Denny T.N., Zeng X., Fang J., Moffett A., Lifson J.D., Goedert J.J., Buchbinder S., Kirk G.D., Fellay J., McLaren P., Deeks S.G., Pereyra F., Walker B., Michael N.L., Weintrob A., Wolinsky S., Liao W., Carrington M. Influence of HLA-C expression level on HIV control. Science 2013, 340(6128):87-91.
3. Arnaout R.A., Lloyd A.L., O'Brien T.R., Goedert J.J., Leonard J.M., Nowak M.A. A simple relationship between viral load and survival time in HIV-1 infection. Proc. Natl. Acad. Sci. USA 1999, 96(20):11549-11553.
4. Baeten J.M., Chohan B., Lavreys L., Chohan V., McClelland R.S., Certain L., Mandaliya K., Jaoko W., Overbaugh J. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J. Infect. Dis. 2007, 195(8):1177-1180.
5. Bansal A., Yue L., Conway J., Yusim K., Tang J., Kappes J., Kaslow R.A., Wilson C.M., Goepfert P.A. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents. AIDS 2007, 21(18):2387-2397.
6. Carrington M., Martin M.P., van Bergen J. KIR-HLA intercourse in HIV disease. Trends Microbiol. 2008, 16(12):620-627.
7. Cohen M.S., Chen Y.Q., McCauley M., Gamble T., Hosseinipour M.C., Kumarasamy N., Hakim J.G., Kumwenda J., Grinsztejn B., Pilotto J.H., Godbole S.V., Mehendale S., Chariyalertsak S., Santos B.R., Mayer K.H., Hoffman I.F., Eshleman S.H., Piwowar-Manning E., Wang L., Makhema J., Mills L.A., de Bruyn G., Sanne I., Eron J., Gallant J., Havlir D., Swindells S., Ribaudo H., Elharrar V., Burns D., Taha T.E., Nielsen-Saines K., Celentano D., Essex M., Fleming T.R. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 2011, 365(6):493-505.
8. Cole S.R., Napravnik S., Mugavero M.J., Lau B., Eron J.J., Saag M.S. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am. J. Epidemiol. 2010, 171(2):198-205.
9. Cousins, Konikoff, Laeyendecker, Celum, Buchbinder, Seage, Kirk, Moore, Mehta, Margolick, Brown, Mayer, Koblin, Wheeler, Justman, Hodder, Quinn, Brookmeyer and Eshleman, HIV diversity as a biomarker for HIV incidence estimation: including a high resolution melting diversity assay in a multi-assay algorithm, J. Clin. Microbiol. PMID: 24153134, in press.
10. Craney T.A., Surles J.G. Model-dependent variance inflation factor cutoff values. Qual. Eng. 2002, 14(3):391-403.
11. *5703-positive individuals and their transmission recipients. J. Exp. Med. 2009, 206(4):909-921.
12. Dunkle K.L., Stephenson R., Karita E., Chomba E., Kayitenkore K., Vwalika C., Greenberg L., Allen S. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 2008, 371(9631):2183-2191.
13. *18 and protection against mother-to-child HIV type 1 transmission. AIDS Res. Hum. Retrovir. 2004, 20(7):692-697.
14. Fellay J., Ge D., Shianna K.V., Colombo S., Ledergerber B., Cirulli E.T., Urban T.J., Zhang K., Gumbs C.E., Smith J.P., Castagna A., Cozzi-Lepri A., De Luca A., Easterbrook P., Gunthard H.F., Mallal S., Mussini C., Dalmau J., Martinez-Picado J., Miro J.M., Obel N., Wolinsky S.M., Martinson J.J., Detels R., Margolick J.B., Jacobson L.P., Descombes P., Antonarakis S.E., Beckmann J.S., O'Brien S.J., Letvin N.L., McMichael A.J., Haynes B.F., Carrington M., Feng S., Telenti A., Goldstein D.B. Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 2009, 5(12):e1000791.
15. Fideli U.S., Allen S., Musunda R., Trask S., Hahn B., Mulenga J., Kasolo F.C., Vermund S.H., Aldrovandi G. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 (HIV-1) in Africa. AIDS Res. Hum. Retrovir. 2001, 17(10):901-910.
16. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., Heldebrant C., Smith R., Conrad A., Kleinman S.H., Busch M.P. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17(13):1871-1879.
17. Gao X., O'Brien T.R., Welzel T.M., Marti D., Qi Y., Goedert J.J., Phair J., Pfeiffer R., Carrington M. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS 2010, 24(12):1835-1840.
18. Kaleebu P., Ross A., Morgan D., Yirrell D., Oram J., Rutebemberwa A., Lyagoba F., Hamilton L., Biryahwaho B., Whitworth J. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 2001, 15(3):293-299.
19. Karita E., Price M., Hunter E., Chomba E., Allen S., Fei L., Kamali A., Sanders E.J., Anzala O., Katende M., Ketter N. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007, 21(4):403-408.
20. Kawashima Y., Pfafferott K., Frater J., Matthews P., Payne R., Addo M., Gatanaga H., Fujiwara M., Hachiya A., Koizumi H., Kuse N., Oka S., Duda A., Prendergast A., Crawford H., Leslie A., Brumme Z., Brumme C., Allen T., Brander C., Kaslow R., Tang J., Hunter E., Allen S., Mulenga J., Branch S., Roach T., John M., Mallal S., Ogwu A., Shapiro R., Prado J.G., Fidler S., Weber J., Pybus O.G., Klenerman P., Ndung'u T., Phillips R., Heckerman D., Harrigan P.R., Walker B.D., Takiguchi M., Goulder P. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009, 458(7238):641-645.
21. Kiwanuka N., Laeyendecker O., Robb M., Kigozi G., Arroyo M., McCutchan F., Eller L.A., Eller M., Makumbi F., Birx D., Wabwire-Mangen F., Serwadda D., Sewankambo N.K., Quinn T.C., Wawer M., Gray R. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J. Infect. Dis. 2008, 197(5):707-713.
22. Kozak M., Zinski A., Leeper C., Willig J.H., Mugavero M.J. Late diagnosis, delayed presentation and late presentation in HIV: proposed definitions, methodological considerations and health implications. Antivir. Ther. 2013, 18(1):17-23.
23. Lazaryan A., Song W., Lobashevsky E., Tang J., Shrestha S., Zhang K., McNicholl J.M., Gardner L.I., Wilson C.M., Klein R.S., Rompalo A., Mayer K., Sobel J., Kaslow R.A. The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum. Immunol. 2011, 72(4):312-318.
24. Leslie A., Matthews P.C., Listgarten J., Carlson J.M., Kadie C., Ndung'u T., Brander C., Coovadia H., Walker B.D., Heckerman D., Goulder P.J. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J. Virol. 2010, 84(19):9879-9888.
25. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., Altfeld M., Brander C., Dixon C., Ramduth D., Jeena P., Thomas S.A., John A., Roach T.A., Kupfer B., Luzzi G., Edwards A., Taylor G., Lyall H., Tudor-Williams G., Novelli V., Martinez-Picado J., Kiepiela P., Walker B.D., Goulder P.J. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 2004, 10(3):282-289.
26. Lyles C.M., Dorrucci M., Vlahov D., Pezzotti P., Angarano G., Sinicco A., Alberici F., Alcorn T.M., Vella S., Rezza G. Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. J. Infect. Dis. 1999, 180(4):1018-1024.
27. McLaren P.J., Ripke S., Pelak K., Weintrob A.C., Patsopoulos N.A., Jia X., Erlich R.L., Lennon N.J., Kadie C.M., Heckerman D., Gupta N., Haas D.W., Deeks S.G., Pereyra F., Walker B.D., de Bakker P.I. Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African-Americans. Hum. Mol. Genet. 2012, 21(19):4334-4347.
28. Mellors J.W., Kingsley L.A., Rinaldo C.R., Todd J.A., Hoo B.S., Kokka R.P., Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 1995, 122(8):573-579.
29. Mellors J.W., Margolick J.B., Phair J.P., Rinaldo C.R., Detels R., Jacobson L.P., Munoz A. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. J. Am. Med. Assoc. 2007, 297(21):2349-2350.
30. Merino A.M., Sabbaj S., Easlick J., Goepfert P., Kaslow R.A., Tang J. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Clin. Exp. Immunol. 2013, 174(3):414-423.
31. Merino A.M., Song W., He D., Mulenga J., Allen S., Hunter E., Tang J., Kaslow R.A. HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral load. J. Infect. Dis. 2012, 205(12):1797-1805.
32. Montaner J.S., Lima V.D., Barrios R., Yip B., Wood E., Kerr T., Shannon K., Harrigan P.R., Hogg R.S., Daly P., Kendall P. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010, 376(9740):532-539.
33. Mugavero M.J., Amico K.R., Westfall A.O., Crane H.M., Zinski A., Willig J.H., Dombrowski J.C., Norton W.E., Raper J.L., Kitahata M.M., Saag M.S. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J. Acquir. Immune Defic. Syndr. 2012, 59(1):86-93.
34. Mugavero M.J., Napravnik S., Cole S.R., Eron J.J., Lau B., Crane H.M., Kitahata M.M., Willig J.H., Moore R.D., Deeks S.G., Saag M.S. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin. Infect. Dis. 2011, 53(9):927-935.
35. Ngongo P.B., Priddy F., Park H., Becker J., Bender B., Fast P., Anzala O., Mutua G., Ruzagira E., Kamali A., Karita E., Mugo P., Chomba E., Bekker L.G., Roux S., Nanvubya A., Mebrahtu T. Developing standards of care for HIV prevention research in developing countries-a case study of 10 research centers in Eastern and Southern Africa. AIDS Care 2012, 24(10):1277-1289.
36. Novitsky V., Wang R., Margolin L., Baca J., Moyo S., Musonda R., Essex M. Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection. Virology 2010, 403(1):37-46.
37. Osmanov S., Pattou C., Walker N., Schwardlander B., Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J. Acquir. Immune Defic. Syndr. 2002, 29(2):184-190.
38. *81 in HIV-1 infection: slow and steady wins the race?. J. Virol. 2013, 87(7):4043-4051.
39. Prentice H.A., Tang J. HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues. Viruses 2012, 4(10):2080-2096.
40. Price M.A., Wallis C.L., Lakhi S., Karita E., Kamali A., Anzala O., Sanders E.J., Bekker L.G., Twesigye R., Hunter E., Kaleebu P., Kayitenkore K., Allen S., Ruzagira E., Mwangome M., Mutua G., Amornkul P.N., Stevens G., Pond S.L., Schaefer M., Papathanasopoulos M.A., Stevens W., Gilmour J. Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. AIDS Res. Hum. Retrovir. 2011, 27(1):5-12.
41. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., Meehan M.O., Lutalo T., Gray R.H. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 2000, 342(13):921-929.
42. Rodriguez B., Sethi A.K., Cheruvu V.K., Mackay W., Bosch R.J., Kitahata M., Boswell S.L., Mathews W.C., Bangsberg D.R., Martin J., Whalen C.C., Sieg S., Yadavalli S., Deeks S.G., Lederman M.M. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. J. Am. Med. Assoc. 2006, 296(12):1498-1506.
43. Shrestha S., Aissani B., Song W., Wilson C.M., Kaslow R.A., Tang J. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 2009, 23(6):673-677.
44. Song W., He D., Brill I., Malhotra R., Mulenga J., Allen S., Hunter E., Tang J., Kaslow R.A. Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population. PLoS One 2011, 6(8):e23469.
45. Stewart C.A., Laugier-Anfossi F., Vely F., Saulquin X., Riedmuller J., Tisserant A., Gauthier L., Romagne F., Ferracci G., Arosa F.A., Moretta A., Sun P.D., Ugolini S., Vivier E. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA 2005, 102(37):13224-13229.
46. *57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes. J. Virol. 2011, 85(17):8894-8902.
47. Tang J., Malhotra R., Song W., Brill I., Hu L., Farmer P.K., Mulenga J., Allen S., Hunter E., Kaslow R.A. Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS One 2010, 5(3):e9629.
48. Tang J., Shao W., Yoo Y.J., Brill I., Mulenga J., Allen S., Hunter E., Kaslow R.A. Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples. J. Immunol. 2008, 181(4):2626-2635.
49. Tang J., Shelton B., Makhatadze N.J., Zhang Y., Schaen M., Louie L.G., Goedert J.J., Seaberg E.C., Margolick J.B., Mellors J., Kaslow R.A. Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression. J. Virol. 2002, 76(2):662-672.
50. Tang J., Tang S., Lobashevsky E., Myracle A.D., Fideli U., Aldrovandi G., Allen S., Musonda R., Kaslow R.A. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J. Virol. 2002, 76(16):8276-8284.
51. Tebit D.M., Arts E.J. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect. Dis. 2011, 11(1):45-56.
52. Vasan A., Renjifo B., Hertzmark E., Chaplin B., Msamanga G., Essex M., Fawzi W., Hunter D. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin. Infect. Dis. 2006, 42(6):843-852.
53. Wang Y.E., Li B., Carlson J.M., Streeck H., Gladden A.D., Goodman R., Schneidewind A., Power K.A., Toth I., Frahm N., Alter G., Brander C., Carrington M., Walker B.D., Altfeld M., Heckerman D., Allen T.M. Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J. Virol. 2009, 83(4):1845-1855.
54. Yue L., Prentice H.A., Farmer P., Song W., He D., Lakhi S., Goepfert P., Gilmour J., Allen S., Tang J., Kaslow R.A., Hunter E. Cumulative impact of host and viral factors on HIV-1 viral load control during early infection. J. Virol. 2013, 87(2):708-715.